Royalty Pharma plc (RPRX) – Hot M&A
-
Ionis Pharmaceuticals (IONS), Royalty Pharma (RPRX) enter into royalty agreement for up to $1.1 billion
-
Theravance Biopharma (TBPH) to Sell TRELEGY ELLIPTA Royalty Interests to Royalty Pharma (RPRX) for Approximately $1.1 Billion in Upfront Cash with Over $1.5 Billion in Potential Total Value
-
-
-
Back to RPRX Stock Lookup